Tweets
Effect of voclosporin in class V lupus nephritis
Dr. Yusof ( @Yuz6Yusof) discusses abstract 0355 presented at #ACR22. Abstract 0355: Long-term Use of Voclosporin in Patients with Class V Lupus Nephritis: Results from the AURORA 2 Continuation Study
https://t.co/v716QGx73g https://t.co/ANTOEDAAHt
Links:
Dr. John Cush @RheumNow ( View Tweet )
3 years 7 months ago
The CONSUL Trial: Ankylosing Spondylitis
Dr. Sheila Reyes ( @RHEUMarampa) discusses abstract 0546 presented at #ACR22.
https://t.co/DXTn3XfEzC https://t.co/pbORtBsRm2
Links:
Dr. John Cush @RheumNow ( View Tweet )
3 years 7 months ago
JAK vs TNF inhibitor Infections in RA
Dr. David Liew ( @drdavidliew) discusses abstract 0302 at #ACR22 Convergence. Abstract 0302: Risk of Infections Between JAK Inhibitors and TNF Inhibitors Among Patients with Rheumatoid Arthritis
https://t.co/GsOsWtuT7v https://t.co/GloKEcB75L
Links:
Dr. John Cush @RheumNow ( View Tweet )
3 years 7 months ago
Does BASDAI work for women?
In Abstract 0406 S. Maguire et al sought to understand if BASDAI and BASFI captured disease activity and quality of life in female axSpA patients.
Read more from Dr. Rachel Tate ( @uptoTate ) #ACR22
https://t.co/yWzdRMPgpp https://t.co/YrMsAYbAWN
Links:
Dr. John Cush @RheumNow ( View Tweet )
3 years 7 months ago
ACR Best Abstracts - Day 3
The last day was jammed with important reports and research including the late breaking abstracts. These were some of our favorites. #ACR22
https://t.co/vUrxBTF3Wj https://t.co/QKpTjyFfxt
Links:
Dr. John Cush @RheumNow ( View Tweet )
3 years 7 months ago
#ACR22 final plenary session
10 week study outcomes of Philly vs Placebo to be reported
#rheumpix @RheumNow https://t.co/BradH2Ty70
Eric Dein @ericdeinmd ( View Tweet )
3 years 8 months ago
Can you put a bit of morphine intraarticularly inside an osteoarthritic knee and make it better?
Cute idea, no bingo.
I get that we're chasing better symptomatic solutions, but...
Don't do this.
ABST1833 #ACR22 @RheumNow https://t.co/pvsGx93eoU
David Liew @drdavidliew ( View Tweet )
3 years 8 months ago
Erosive OA:
have we got anything disease-modifying?
Not much right now (read: nothing)
Denosumab 60mg q3mo for bone remodelling?
radiographic change, erosive jt development: real improvement
pain, function: zip at 48w, some at 96w?
Def worth more study!
ABSTL05 #ACR22 @RheumNow https://t.co/Yo9u5BlYYJ
David Liew @drdavidliew ( View Tweet )
3 years 8 months ago
PAN relapse risk ⬆️ in:
👉severe GI involvement
🧓>65y/o
👉skin necrotic lesions
PAN ⬆️ mortality wt:
👉AKI
🧓>65y/o
👉necrotic purpura
👉secondary PAN
Abst#2232 @RheumNow #ACR22
Patricia Harkins @DrTrishHarkins ( View Tweet )
3 years 8 months ago
Abstr #2196- COVID-19 outcomes in IMID dx in large US Hospital
vs Pre-Omicron
- ↑ COVID + rate (21.9% vs 7.9%)
- ↓ hospitalized (0.8% vs 3%) & death (1.8% vs 4.5%)
- Hospitalization & death > gen pop both pd.
-Age & comorbidities assoc w worse outcomes
@RheumNow #ACR22
Akhil Sood MD @AkhilSoodMD ( View Tweet )
3 years 8 months ago
Biosimilar multi-switching in RA: is it an issue?
Switching back & forth between originator & biosimilar should create ideal conditions for immunogenicity or anti-drug Ab
This study: multi-switching vs no switching
No issues at all
Switch away in RA!
ABST1589 #ACR22 @RheumNow https://t.co/pGBF2BHp7y
David Liew @drdavidliew ( View Tweet )
3 years 8 months ago
We want to see how you are taking in #ACR22! Share your favorite pictures from ACR on Twitter and tag #RheumPix and #ACR22 and we'll re-tweet our favorite ones! https://t.co/ygfYol5Z3f
Dr. John Cush @RheumNow ( View Tweet )
3 years 8 months ago
